Clinical trials are designed not just to test whether a treatment works, but to do so in a way that eliminates bias. Two common trial designs—open-label and double-blind—differ sharply in this ...
The first platform trial for amyotrophic lateral sclerosis (ALS), which individually evaluated four experimental drugs, failed to meet key primary endpoints. Still, investigators view the trial as ...
Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback